Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
University of Kansas Medical Center · with National Institute on Aging (NIA), University of Puerto Rico · NCT06728436
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 288
- US sites recruiting
- 1
- Study start
- February 17, 2025
- Record last updated
- December 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos.
Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences .
Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.
Being studied: CuidaTEXT
Conditions: Alzheimer Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Over the age of 18
- Spanish and English-speaking people who identify as Latino
- Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
- Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
- Self-reports being able to read and write
- Owns a cell phone with a flat fee, and uses it at least weekly for texting.
Exclusion Criteria
- Participation in another wellbeing-related clinical trial
- Cohabitation with another participant in the CuidaTEXT R01 Study
- Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
- Participant plans to move to another country within seven months
Recruiting US locations
University of Kansas Medical Center
Fairway, KS 66205
Site contact: Rachel Ruiz · 913-945-5052 · rruiz3@kumc.edu
Study contacts (from the official record)
- Rachel Ruiz · 913-945-5052 · rruiz3@kumc.edu
- Jaime Perales Puchalt, PhD, MPH · 913-588-3716 · jperales@kumc.edu
Similar studies in Kansas
All neurology studies in Kansas →- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Overland Park, KS + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Kansas City, KS + 24 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Overland Park, KS + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Roeland Park, KS + 24 other US sites
- Eligibility basics
- Ages 18–60